New fast-acting insulin tested against standard in diabetes trial
NCT ID NCT04588259
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new fast-acting insulin (faster aspart) against a standard insulin (NovoRapid) in 331 adults with type 1 or type 2 diabetes. Both were taken with a long-acting insulin (insulin degludec) for 16 weeks. The goal was to see if the new insulin works better at controlling blood sugar, especially after meals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fast-acting insulin aspart
What this could lead to
If it works, this could offer a faster-acting insulin option for better blood sugar control after meals.
What could go wrong
This is a completed Phase 3 trial, but results may not show meaningful improvement over existing insulins. Risks include low blood sugar and injection site reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Provincial Hospital-Endocrinology
Hefei, Anhui, 230001, China
-
Beijing Chao-Yang Hospital, Capital Medical University-Endocrinology
Beijing, Beijing Municipality, 100020, China
-
Beijing Pinggu Hospital-Endocrinology
Beijing, Beijing Municipality, 101200, China
-
Cangzhou People's Hospital-Endocrinology
Cangzhou, Hebei, 061000, China
-
Central Hospital of Minhang District, Shanghai-Endocrinology
Shanghai, Shanghai Municipality, 201199, China
-
Changzhou No.2 People's Hospital, Yanghu Branch
Changzhou, Jiangsu, 213003, China
-
China-Japan Union Hospital of Jilin University-Endocrinology
Changchun, Jilin, 130033, China
-
Chinese People's Liberation Army General Hospital-Endocrinology
Beijing, Beijing Municipality, 100853, China
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
First Affiliated Hospital of Kunming Medical University-Endocrinology
Kunming, Yunnan, 650032, China
-
General Hospital of Tianjin Medical University-Endocrinology
Tianjin, Tianjin Municipality, 300052, China
-
Hengshui People's Hospital (Harrison International Peace Hospital)-Endocrinology
Hengshui, Hebei, 053000, China
-
Inner Mongolia People's Hospital-Endocrinology
Hohhot, Inner Mongolia, 010020, China
-
Jiangsu Province Hospital-Endocrinology
Nanjing, Jiangsu, 210029, China
-
Jiangxi Provincial People's Hospital-Endocrinology
Nanchang, Jiangxi, 330006, China
-
Jinan Central Hospital Affiliated to Shandong University
Jinan, Shandong, 250013, China
-
Master Centre for Hong Kong
Kowloon, Hong Kong
-
Nanjing Jiangning Hospital-Endocrinology
Nanjing, Jiangsu, 211199, China
-
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
-
Qinghai Provincial People's Hospital
Xining, Qinghai, 810007, China
-
Shanghai Fifth People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 200240, China
-
Shanghai Tenth People's Hospital (Tenth People's of Tongji University)-Endocrinology
Shanghai, Shanghai Municipality, 200072, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
-
Suzhou Municipal Hospital-Endocrinology
Suzhou, Jiangsu, 215002, China
-
Tangshan Gongren Hospital-Endocrinology
Tangshan, Hebei, 063000, China
-
The Affiliated Hospital of Jiangsu University-Endocrinology
Zhenjiang, Jiangsu, 212001, China
-
The Fifth Medical Center of PLA General Hospital-Endocrinology
Beijing, Beijing Municipality, 100071, China
-
The First Affiliated Hospital of Anhui Medical University-Endocrinology
Hefei, Anhui, 230061, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Bethune hospital of Jilin University-Endocrinology
Changchun, Jilin, 130061, China
-
The First People's Hospital of Yunnan Province-Endocrinology
Kunming, Yunnan, 650032, China
-
The General Hospital of the PLA Rocket Force-Endocrinology
Beijing, Beijing Municipality, 100088, China
-
The Second Affiliated Hospital of Guangxi Medical University-Endocrinology
Nanning, Guangxi, 530006, China
-
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650101, China
-
The Second Affiliated Hospital of Nanjing Medical University-Endocrinology
Nanjing, Jiangsu, 210011, China
-
The Second Affiliated Hospital of Shantou University Medical College-Endocrinology
Shantou, Guangdong, 515065, China
-
The Second Hospital of Hebei Medical University-Endocrinology
Shijiazhuang, Hebei, 050000, China
-
The Second Hospital of Jilin University
Changchun, Jilin, 130041, China
-
The affiliated Hospital of Inner Mongolia Medical University-Endocrinology
Hohhot, Inner Mongolia, 010050, China
-
Yueyang Central Hospital-Endocrinology
Yueyang, Hunan, 414000, China